Filana Therapeutics, Inc. Payments of Financing Costs
Filana Therapeutics, Inc. (FLNA) reported Payments of Financing Costs of $70.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-02-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2018-02-06
- Filana Therapeutics, Inc. payments of financing costs for the quarter ending 2016-12-31 was $24.00K.
- Filana Therapeutics, Inc. payments of financing costs for the quarter ending 2016-09-30 was $0.00.
- Filana Therapeutics, Inc. payments of financing costs for the quarter ending 2016-06-30 was $0.00.
- Filana Therapeutics, Inc. payments of financing costs for the quarter ending 2016-03-31 was $46.00K.
- Filana Therapeutics, Inc. payments of financing costs for fiscal 2016 was $70.00K, a 52.17% increase from fiscal 2015.
- Filana Therapeutics, Inc. payments of financing costs for fiscal 2015 was $46.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2016-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-06 | $24.00K derived: sum of 2 quarters · filed 2018-02-06 | $24.00K derived: sum of 3 quarters · filed 2018-02-06 | $70.00K 10-K · filed 2018-02-06 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $46.00K 10-Q · filed 2017-11-01 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $46.00K 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $46.00K 10-Q · filed 2017-04-26 | |||
| 2015-12-31 | $46.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |